Phase 1 Solid Tumors (Phase 1) Clinical Trials
6 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–6 of 6 trials
Recruiting
Phase 1
Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations
RAS MutationSolid Tumors (Phase 1)
Adlai Nortye Biopharma Co., Ltd.118 enrolled3 locationsNCT07252479
Recruiting
Phase 1
First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors
Solid Tumors (Phase 1)
Adcendo ApS180 enrolled7 locationsNCT07362888
Recruiting
Phase 1
Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation
Solid Tumors (Phase 1)
Haisco Pharmaceutical Group Co., Ltd.159 enrolled2 locationsNCT07561554
Recruiting
Phase 1
A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors
Solid Tumors (Phase 1)
Abbisko Therapeutics Co, Ltd266 enrolled1 locationNCT07288957
Recruiting
Phase 1
Safety and Tolerability Evaluation of CEL001 Injection in Advanced Solid Tumors
Advanced Solid Tumors (Phase 1)
Guangzhou Xiling Biotechnology Co., Ltd.13 enrolled1 locationNCT07259889
Recruiting
Phase 1
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Gastric CancerCervical CancerCancer+7 more
Rondo Therapeutics149 enrolled2 locationsNCT07218003